Literature DB >> 35717489

Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia.

Marcia S Murta1, Ricardo L M Duarte2, Daniel Waetge1, David Gozal3, Alexandre P Cardoso1, Fernanda C Q Mello1.   

Abstract

PURPOSE: To evaluate the frequency of sleep-disordered breathing (SDB) and predictors of the presence of nocturnal desaturation in adults with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
METHODS: Outpatients with a hemodynamic diagnosis of precapillary pulmonary hypertension who underwent portable polysomnography were evaluated. Diagnosis and severity of SDB were assessed using three well-established respiratory disturbance index (RDI) thresholds: 5.0/h, 15.0/h, and 30.0/h, while nocturnal hypoxemia was defined by the average oxygen saturation (SpO2) < 90%. Multiple linear regression analysis evaluated the potential relationships among explanatory variables with the dependent variable (average SpO2 values), with comparisons based on the standardized regression coefficient (β). The R-squared (R2; coefficient of determination) was used to evaluate the goodness-of-fit measure for the linear regression model.
RESULTS: Thirty-six adults were evaluated (69.4% females). The majority of the participants (75.0%) had SDB (26 with obstructive sleep apnea [OSA] and one with central sleep apnea [CSA]); while 50% of them had nocturnal hypoxemia. In the linear regression model (R2 = 0.391), the mean pulmonary artery pressure [mPAP] (β - 0.668; p = 0.030) emerged as the only independent parameter of the average SpO2.
CONCLUSION: Our study found that the majority of the participants had some type of SDB with a marked predominance of OSA over CSA, while half of them had nocturnal desaturation. Neither clinical and hemodynamic parameters nor the RDI was a predictor of nocturnal desaturation, except for mPAP measured during a right heart catheterization, which emerged as the only independent and significant predictor of average SpO2.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Nocturnal hypoxemia; Polysomnography; Pulmonary hypertension; Sleep-disordered breathing

Mesh:

Year:  2022        PMID: 35717489     DOI: 10.1007/s00408-022-00547-w

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  40 in total

1.  Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  Vishesh K Kapur; Dennis H Auckley; Susmita Chowdhuri; David C Kuhlmann; Reena Mehra; Kannan Ramar; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

Review 2.  The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis.

Authors:  Nader Salari; Habibolah Khazaie; Maryam Abolfathi; Hooman Ghasemi; Shervin Shabani; Shna Rasoulpoor; Masoud Mohammadi; Shabnam Rasoulpoor; Behnam Khaledi-Paveh
Journal:  Neurol Sci       Date:  2021-11-19       Impact factor: 3.830

3.  Mortality and morbidity in obstructive sleep apnoea-hypopnoea syndrome: results from a 30-year prospective cohort study.

Authors:  Sophie Dodds; Linda J Williams; Amber Roguski; Marjorie Vennelle; Neil J Douglas; Serafeim-Chrysovalantis Kotoulas; Renata L Riha
Journal:  ERJ Open Res       Date:  2020-09-14

4.  Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome.

Authors:  N Pelletier-Fleury; N Meslier; F Gagnadoux; C Person; D Rakotonanahary; H Ouksel; B Fleury; J L Racineux
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

5.  The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database.

Authors:  Babak Mokhlesi; Sandra A Ham; David Gozal
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

6.  Incremental health care utilization and expenditures for sleep disorders in the United States.

Authors:  Phillip Huyett; Neil Bhattacharyya
Journal:  J Clin Sleep Med       Date:  2021-10-01       Impact factor: 4.324

7.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

8.  Diagnosis of pulmonary hypertension.

Authors:  Adaani Frost; David Badesch; J Simon R Gibbs; Deepa Gopalan; Dinesh Khanna; Alessandra Manes; Ronald Oudiz; Toru Satoh; Fernando Torres; Adam Torbicki
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

9.  Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review.

Authors:  Laurence Leber; Amélie Beaudet; Audrey Muller
Journal:  Pulm Circ       Date:  2021-01-07       Impact factor: 3.017

10.  Risk of mortality among patients with moderate to severe obstructive sleep apnea and diabetes mellitus: results from the SantOSA cohort.

Authors:  Gonzalo Labarca; Jorge Dreyse; Constanza Salas; Alexia Schmidt; Francisca Rivera; Francisca Letelier; Jorge Jorquera
Journal:  Sleep Breath       Date:  2021-01-04       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.